Health Canada Approval of Alecensaro® as First Adjuvant Treatment for ALK-Positive Early-Stage Lung Cancer

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.